IL-10 is known as an immunosuppressive cytokine and our findings support the results of previous studies that reported upregulated IL-10 expression in the peripheral nerves of patients with CIDP [44, 45] and elevated IL10 production in PBMC in patients with active CIDP compared to healthy controls [46]. Here, IL10 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.